Annual Cash & Cash Equivalents
$295.39 M
+$221.04 M+297.27%
December 31, 2023
Summary
- As of February 7, 2025, SNDX annual cash & cash equivalents is $295.39 million, with the most recent change of +$221.04 million (+297.27%) on December 31, 2023.
- During the last 3 years, SNDX annual cash & cash equivalents has risen by +$180.15 million (+156.32%).
- SNDX annual cash & cash equivalents is now at all-time high.
Performance
SNDX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$133.02 M
+$27.62 M+26.21%
September 30, 2024
Summary
- As of February 7, 2025, SNDX quarterly cash and cash equivalents is $133.02 million, with the most recent change of +$27.62 million (+26.21%) on September 30, 2024.
- Over the past year, SNDX quarterly cash and cash equivalents has increased by +$38.47 million (+40.69%).
- SNDX quarterly cash and cash equivalents is now -54.97% below its all-time high of $295.39 million, reached on December 31, 2023.
Performance
SNDX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SNDX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +297.3% | +40.7% |
| 3 y3 years | +156.3% | -29.5% |
| 5 y5 years | +774.8% | -29.5% |
SNDX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +297.3% | -55.0% | +131.3% |
| 5 y | 5-year | at high | +1100.3% | -55.0% | +440.5% |
| alltime | all time | at high | >+9999.0% | -55.0% | +2742.3% |
Syndax Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $133.02 M(+26.2%) |
| Jun 2024 | - | $105.40 M(-8.0%) |
| Mar 2024 | - | $114.61 M(-61.2%) |
| Dec 2023 | $295.39 M(+297.3%) | $295.39 M(+212.4%) |
| Sep 2023 | - | $94.55 M(-2.8%) |
| Jun 2023 | - | $97.28 M(+69.1%) |
| Mar 2023 | - | $57.52 M(-22.6%) |
| Dec 2022 | $74.36 M(-66.5%) | $74.36 M(+4.2%) |
| Sep 2022 | - | $71.38 M(-40.6%) |
| Jun 2022 | - | $120.24 M(-36.3%) |
| Mar 2022 | - | $188.77 M(-15.0%) |
| Dec 2021 | $221.97 M(+92.6%) | $221.97 M(+210.7%) |
| Sep 2021 | - | $71.43 M(+5.0%) |
| Jun 2021 | - | $68.04 M(+5.7%) |
| Mar 2021 | - | $64.39 M(-44.1%) |
| Dec 2020 | $115.24 M(+368.3%) | $115.24 M(+104.5%) |
| Sep 2020 | - | $56.36 M(+5.1%) |
| Jun 2020 | - | $53.61 M(+20.1%) |
| Mar 2020 | - | $44.63 M(+81.4%) |
| Dec 2019 | $24.61 M | $24.61 M(-19.5%) |
| Sep 2019 | - | $30.58 M(+14.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $26.67 M(-54.1%) |
| Mar 2019 | - | $58.12 M(+72.1%) |
| Dec 2018 | $33.77 M(-4.0%) | $33.77 M(+26.5%) |
| Sep 2018 | - | $26.70 M(-17.1%) |
| Jun 2018 | - | $32.20 M(+15.1%) |
| Mar 2018 | - | $27.98 M(-20.4%) |
| Dec 2017 | $35.17 M(+47.5%) | $35.17 M(+69.6%) |
| Sep 2017 | - | $20.73 M(-9.8%) |
| Jun 2017 | - | $22.99 M(+2.8%) |
| Mar 2017 | - | $22.36 M(-6.2%) |
| Dec 2016 | $23.84 M(+2.9%) | $23.84 M(+87.0%) |
| Sep 2016 | - | $12.75 M(-11.7%) |
| Jun 2016 | - | $14.44 M(-37.7%) |
| Mar 2016 | - | $23.19 M(+0.0%) |
| Dec 2015 | $23.18 M(+131.6%) | $23.18 M(-57.2%) |
| Sep 2015 | - | $54.21 M(+441.7%) |
| Dec 2014 | $10.01 M(-0.9%) | $10.01 M(-13.6%) |
| Sep 2014 | - | $11.59 M(+147.6%) |
| Jun 2014 | - | $4.68 M(-31.6%) |
| Mar 2014 | - | $6.84 M(-32.3%) |
| Dec 2013 | $10.10 M(+1781.6%) | $10.10 M |
| Dec 2012 | $537.00 K | - |
FAQ
- What is Syndax Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Syndax Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Syndax Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of SNDX is $295.39 M
What is the all time high annual cash & cash equivalents for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual cash & cash equivalents is $295.39 M
What is Syndax Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, SNDX annual cash & cash equivalents has changed by +$221.04 M (+297.27%)
What is Syndax Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SNDX is $133.02 M
What is the all time high quarterly cash and cash equivalents for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly cash and cash equivalents is $295.39 M
What is Syndax Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, SNDX quarterly cash and cash equivalents has changed by +$38.47 M (+40.69%)